$ADPT Adaptive Biotechnologies Corp Insider Trading Week 26/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp in week 26/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | P | 20.00 | 1,000 | 20,000 | 1,000 | 0 to 1,000 |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | Sr Vice President, ... | Buy | P | 20.00 | 300 | 6,000 | 300 | 0 to 300 |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | Sr Vice President, ... | Buy | P | 20.00 | 400 | 8,000 | 400 | 0 to 400 |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | Sr Vice President, ... | Buy | P | 20.00 | 500 | 10,000 | 500 | 0 to 500 |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | Sr Vice President, ... | Buy | P | 20.00 | 10,000 | 200,000 | 10,000 | 0 to 10 K |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | C | 0.00 | 223,082 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | C | 0.00 | 454,545 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | C | 0.00 | 1,895,806 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | C | 0.00 | 992,583 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | C | 0.00 | 300,000 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Buy | C | 0.00 | 223,082 | 0 | 3,866,016 | 3.6 M to 3.9 M (+6.12 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Buy | C | 0.00 | 454,545 | 0 | 3,642,934 | 3.2 M to 3.6 M (+14.26 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Buy | C | 0.00 | 1,895,806 | 0 | 3,188,389 | 1.3 M to 3.2 M (+146.67 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Buy | C | 0.00 | 992,583 | 0 | 1,292,583 | 300 K to 1.3 M (+330.86 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Buy | C | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | C | 0.00 | 70,680 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | C | 0.00 | 70,680 | 0 | 1,858,180 | 1.8 M to 1.9 M (+3.95 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | C | 0.00 | 70,679 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | C | 0.00 | 70,679 | 0 | 70,679 | 0 to 70.7 K |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Option Exercise | C | 10.67 | 84,359 | 899,992 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Option Exercise | C | 8.97 | 11,154,116 | 99,999,996 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Option Exercise | C | 6.04 | 5,893,716 | 35,591,562 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Option Exercise | C | 1.00 | 200,000 | 200,000 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Buy | C | 0.00 | 84,359 | 0 | 17,332,191 | 17.2 M to 17.3 M (+0.49 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Buy | C | 0.00 | 11,154,116 | 0 | 17,247,832 | 6.1 M to 17.2 M (+183.04 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Buy | C | 0.00 | 5,893,716 | 0 | 6,093,716 | 200 K to 6.1 M (+2,946.86 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Buy | C | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 290,572 | 0 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,007,740 | 0 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 15,524,350 | 0 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 18,908,945 | 0 | 0 | |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 290,572 | 0 | 38,406,607 | 38.1 M to 38.4 M (+0.76 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 2,007,740 | 0 | 38,116,035 | 36.1 M to 38.1 M (+5.56 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 15,524,350 | 0 | 36,108,295 | 20.6 M to 36.1 M (+75.42 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 18,908,945 | 0 | 20,583,945 | 1.7 M to 20.6 M (+1,128.89 %) |
| Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 20.00 | 250,000 | 5,000,000 | 1,675,000 | 1.4 M to 1.7 M (+17.54 %) |